证券代码：300678 证券简称：中科信息 公告编号：2025-075 中科院成都信息技术股份有限公司 关于部分高级管理人员减持计划实施进展 暨减持期限届满的公告 公司高级管理人员钟勇保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 中科院成都信息技术股份有限公司（简称"公司"）于2025年6月 12日在巨潮资讯网（www.cninfo.com.cn）披露了《关于部分高级管理 人员减持股份的预披露公告》（公告编号：2025-056）。公司高级管理 人员钟勇先生计划自该减持预披露公告之日起15个交易日后的3个月内 以集中竞价方式减持本公司股份不超过180,000股（即不超过本公司总 股本的0.06%）。 近日，公司收到钟勇先生出具的《关于减持期限届满的告知函》， 现将相关情况公告如下： 一、股东减持情况 1.股东减持股份情况 | | | | | | 减持占 | | --- | --- | --- | --- | --- | --- | | 股东 名称 | 减持方 式 | 减持期间 | 减持均价 （元/股） | ...

证券日报网讯中科信息（300678）9月26日在互动平台回答投资者提问时表示，目前，公司未参与阿里 云数据中心建设。 ...

Group 1 - The company, Zhongke Information (300678.SZ), has stated that it is currently not involved in the construction of Alibaba Cloud's data centers [1]

Group 1 - The company, Zhongke Information (300678.SZ), has stated that it is currently not involved in the construction of Alibaba Cloud's data centers [1]

Group 1 - The core theme of the forum was "Future Industries and State Capital Empowering Listed Companies," with over 300 listed companies and 250 state-owned representatives attending [2] - Zhongke Information was awarded the title of "Future Information Industry Star Listed Company" for its innovative practices and contributions to the industry [2] - The company has been a pioneer in using artificial intelligence to assist in the digital transformation of various sectors, including smart governance, intelligent manufacturing, smart cities, and smart healthcare [2][3] Group 2 - Zhongke Information is recognized as a leading enterprise in the artificial intelligence industry chain in Sichuan Tianfu New Area and has been selected as one of the first batch of "Intelligent Transformation and Digital Upgrade" suppliers in Sichuan Province [3] - The company has successfully developed and implemented several innovative products, including the EIOD edge intelligent industrial internet platform and various AI products for specific industries [3] - The company aims to focus on high-quality development, optimize its business layout, and enhance its operational and sustainable development capabilities to contribute to industry prosperity and the capital market's high-quality growth [3]

Core Viewpoint - Zhongke Information (300678) has been awarded the "A-share ESG Demonstration Case" honor at the 2025 China Listed Company Yinghua Awards, reflecting its excellence in environmental, social, and governance (ESG) practices [1][2] Group 1: ESG Recognition - The award encompasses both A-share and Hong Kong stock markets, with 15 categories established to evaluate companies based on authoritative and objective criteria [1] - Evaluation metrics include institutional investor recommendations, expert reviews, and public opinion data, focusing on "intrinsic value, growth potential, value companionship, and value harvest" [1] - The recognition highlights the capital market's acknowledgment of the company's standardized governance and its role in empowering green development through AI [1] Group 2: Company Initiatives - Zhongke Information has been committed to the implementation of "AI+ applications" in areas such as smart government, intelligent manufacturing, smart cities, and smart healthcare [1] - The company has developed a series of digital products that support new productivity construction, including the EIOD edge intelligent internet platform, which provides comprehensive solutions for smart factories [1] - Products like machine vision models and data analysis algorithms have enhanced quality and precision in industries such as banknote printing, card manufacturing, glass, and lithium batteries [1] - Intelligent emergency rescue, drone patrol, and smart operation and maintenance products offer safety guarantees in oil and gas fields and pipeline networks [1] Group 3: Future Commitment - The company will continue to uphold sustainable development principles, aiming to meet national major needs and assist industries in improving quality and efficiency [2] - Zhongke Information is dedicated to enhancing its ESG management level and actively fulfilling social responsibilities [2] - The company aims to contribute to the green low-carbon and digital transformation of the industry [2]

Core Viewpoint - The company is actively developing intelligent robots for various sectors, including medical and construction, and is exploring the application of machine vision technology in humanoid robots [2]. Group 1: Company Developments - The company has independently developed an intelligent anesthesia robot for the medical field, which has successfully completed its first clinical trial and is undergoing certification as a Class III medical device [2]. - The intelligent loading robot and intelligent paving robot are multi-modal products that integrate machine vision, intelligent analysis, autonomous driving, and radar communication technologies [2]. - The intelligent loading robot (Phase I) has entered the trial phase, while the intelligent paving robot is currently in the testing phase [2]. Group 2: Industry Applications - The company's high-speed machine vision and intelligent analysis technologies have broad applicability across multiple industry sectors [2]. - There is currently no related business in humanoid robots, but the company is open to exploring collaborations with leading domestic and international humanoid robot companies [2].

Group 1 - The A-share market saw a significant decline in brain-computer interface concept stocks, with several companies experiencing drops of over 5% [1] - Notable companies that fell over 5% include Dineike, Xiangyu Medical, Meihao Medical, Chengdu Huamei, and Tom Cat [1] - Other companies such as Yanshan Technology, Zhongke Information, Aipeng Medical, Nanjing Panda, Weisi Medical, Innovation Medical, Robot, Mailande, Beiqingsong, Botuo Biological, and Rongtai Health dropped over 4% [1]

Group 1: Company Ownership and Control - The actual controller, China Academy of Sciences Holdings Co., Ltd. (CAS Holdings), directly holds 30.53% of the company's shares, maintaining absolute control and leadership [3] - CAS Holdings positions the company as a leader in the artificial intelligence sector, providing resource support [3] Group 2: Strategic Partnerships - The company has had a strategic partnership with West China Hospital for nearly twenty years, focusing on deep collaboration across various departments [4] - The partnership leverages medical big data and artificial intelligence technologies to create specialized solutions and products [4] Group 3: Product Development and Commercialization - The intelligent anesthesia robot has successfully completed its first clinical trial, with plans to obtain Class III medical device certification by the end of 2028 [5] - The company is developing a comprehensive solution for smart hospitals centered around the intelligent anesthesia robot and tumor adaptive radiotherapy platform [5] - The intelligent loading robot is currently in trial use within the Road and Bridge Group, with market promotion underway [6][7] Group 4: Revenue Sources and Business Segments - The main revenue sources include the tobacco business (28%-35% of revenue) and digital conference services (26%-32% of revenue), with other contributions from government, energy, and healthcare sectors [8] - The company has not yet developed brain-computer interface (BCI) technology but is exploring its application in smart medical services [9] Group 5: Technological Advancements and Research - The company has established a doctoral and master's training program at the University of the Chinese Academy of Sciences, supported by an automated reasoning laboratory led by academicians [11] - It has developed a full industrial chain layout for machine vision, ensuring the integration of basic research, key technologies, and industry applications [11]

Group 1: Financial Performance - The company reported a significant increase in new contracts, with a growth rate of 280% in the first half of 2025 compared to the previous year, driven by various business segments [6][25] - The gross profit margin for Q1 2025 was 38.38%, a notable increase from 20.62% for the entire year of 2024, attributed to contributions from multiple business sectors [3][8] - Revenue from the tobacco sector increased by 35.56%, while the oil and gas information sector saw a remarkable growth of 95.85% [25] Group 2: Business Strategy and Market Development - The company is focusing on high-quality development and value maintenance through a strict market value management approach [3][24] - Plans to enhance collaboration with Tesla in the humanoid robot sector were discussed, leveraging the company's expertise in machine vision technology [4][16] - The company aims to expand its market presence in smart healthcare and smart city projects, aligning with national digital transformation initiatives [25][5] Group 3: Product Development and Innovation - The intelligent anesthesia robot has successfully completed its first clinical trial, with ongoing certification processes for medical device registration [9][19] - The company is actively developing a complete AI industrial chain, integrating edge computing and data platforms to support the intelligent anesthesia robot's capabilities [22][28] - The company has established partnerships with various institutions, including Sichuan University Huaxi Hospital, to enhance product development and clinical applications [21][9] Group 4: Investor Relations and Communication - The company emphasizes the importance of investor relations, aiming to enhance understanding and recognition of its value among investors [24][25] - Regular updates and disclosures regarding capital operations and market strategies will be provided to maintain transparency [23][25]